Mark Neumann

Companies

• Veradermics, IncChief Commercial Officer Feb 3, 2026 to now¹
• Intra-Cellular Therapies, Inc.EVP, Chief Commercial Officer Oct 17, 2018 to Apr 2, 2025²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ICIntra-Cellular Therapies, Inc.0 shares³Apr 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 2, 2025Returned to company 52,811 shares at $132.00 of Intra-Cellular Therapies, Inc.³
• Mar 10, 2025Shares withheld for tax 3,116 shares at $131.24 of Intra-Cellular Therapies, Inc.⁴
• Mar 10, 2025Exercised options 7,345 shares of Intra-Cellular Therapies, Inc.⁴
• Mar 6, 2025Shares withheld for tax 5,572 shares at $131.19 of Intra-Cellular Therapies, Inc.⁴
• Mar 6, 2025Exercised options 13,133 shares of Intra-Cellular Therapies, Inc.⁴
• Mar 1, 2025Shares withheld for tax 3,709 shares at $128.20 of Intra-Cellular Therapies, Inc.⁵
• Mar 1, 2025Exercised options 8,742 shares of Intra-Cellular Therapies, Inc.⁵
• Jan 31, 2025Shares withheld for tax 4,729 shares at $127.00 of Intra-Cellular Therapies, Inc.⁶
• Jan 31, 2025Granted 11,017 shares of Intra-Cellular Therapies, Inc.⁶
• Aug 16, 2024Sold 18,714 shares at $75.08 of Intra-Cellular Therapies, Inc.⁷
• Aug 16, 2024Exercised options 18,714 shares at $36.89 of Intra-Cellular Therapies, Inc.⁷
• Mar 11, 2024Sold 1,313 shares at $66.86 of Intra-Cellular Therapies, Inc.⁸
• Mar 11, 2024Sold 1,729 shares at $65.92 of Intra-Cellular Therapies, Inc.⁸
• Mar 11, 2024Sold 4,303 shares at $65.11 of Intra-Cellular Therapies, Inc.⁸
• Mar 10, 2024Exercised options 7,345 shares of Intra-Cellular Therapies, Inc.⁸
• Mar 7, 2024Sold 4,496 shares at $66.95 of Intra-Cellular Therapies, Inc.⁸
• Mar 7, 2024Sold 8,636 shares at $66.37 of Intra-Cellular Therapies, Inc.⁸
• Mar 6, 2024Exercised options 13,132 shares of Intra-Cellular Therapies, Inc.⁹
• Feb 26, 2024Sold 1,307 shares at $71.18 of Intra-Cellular Therapies, Inc.¹⁰
• Feb 26, 2024Sold 2,341 shares at $70.70 of Intra-Cellular Therapies, Inc.¹⁰
• Feb 26, 2024Sold 4,059 shares at $69.56 of Intra-Cellular Therapies, Inc.¹⁰
• Feb 26, 2024Sold 200 shares at $68.03 of Intra-Cellular Therapies, Inc.¹⁰
• Feb 23, 2024Exercised options 7,907 shares of Intra-Cellular Therapies, Inc.¹⁰
• Feb 2, 2024Sold 6,904 shares at $67.49 of Intra-Cellular Therapies, Inc.¹¹
• Feb 2, 2024Sold 4,956 shares at $66.67 of Intra-Cellular Therapies, Inc.¹¹